After graduating from the University of Chicago, Sun joined Dr. Greg Hannon’ group at CSHL and studied tumor heterogeneity in breast cancer. She then joined the Muscle & Metabolism group at Regeneron Pharmaceuticals in Tarrytown, NY and spent her time researching metabolic drug targets for non-alcoholic fatty liver disease. Sun is currently a Ph.D student in Stony Brook Medicine’s Molecular and Cellular Pharmacology program. In The Tuveson Lab, she plans to work on various aspects of pancreatic cancer development such as identification novel biomarkers, integrin-induced tension, and a better understanding of pancreatic-cancer associated metabolic changes.